Rite Aid (RAD) Tops Q3 EPS by 1c, Updates FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
JPMorgan Reiterates Neutral on Rite Aid (RAD) Following 3Q Report
December 21, 2018 7:25 AM ESTJPMorgan analyst, Lisa Gill, reiterated a Neutral rating on Rite-Aid (NYSE: RAD) following the company's 3Q earnings report. Adjusted EBITDA was $13M above forecasts, with upside driven mainly on the gross profit line. Adjusted EPS of +$0.01 compared to estimates of -$0.01.
In the retail... More
Rite Aid (RAD), McKesson (MCK) Announces Terms for Pharmaceutical Purchasing and Distribution
December 19, 2018 4:16 PM ESTRite Aid Corporation (NYSE: RAD) and McKesson Corporation (NYSE: MCK) announced an agreement to key terms that will continue the companies pharmaceutical sourcing and distribution partnership for an additional 10 years. Under these terms, McKesson will continue providing Rite Aid with sourcing and direct-to-store delivery for brand and generic pharmaceutical products through March 2029.
Rite Aid and McKesson have a long history as trusted partners in ensuring the availability of essential medications to patients. The new terms create efficiencies and opportunities for future growth by leveraging the... More
